-
公开(公告)号:EP3442971B1
公开(公告)日:2024-09-25
申请号:EP17776574.0
申请日:2017-03-29
IPC分类号: C07D471/04 , C07D471/14 , C07C61/13 , C07F7/18 , C07C57/04 , C07C69/732 , C07C69/738 , C07C69/757 , C07D209/18 , C07D209/14 , A61K31/437 , A61K31/438 , A61P35/00 , A61P5/30 , C07B59/00
CPC分类号: C07D471/04 , C07C69/732 , C07C69/738 , C07C69/757 , C07B59/002 , C07C2603/6220170501 , A61P5/30 , A61P35/00 , A61K31/437 , A61K31/438 , C07D471/14
-
公开(公告)号:EP4397371A2
公开(公告)日:2024-07-10
申请号:EP24175524.8
申请日:2021-05-19
申请人: Cybin IRL Limited
IPC分类号: A61P25/00
CPC分类号: C07D209/16 , A61K9/2027 , A61K9/2031 , A61K9/2054 , A61K9/2059 , A61P25/00 , C07F9/572 , C07B2200/0520130101 , C07B59/002
摘要: The present disclosure is directed to chemical compounds and to the use of such compounds in the treatment of diseases associated with a serotonin 5-HT2 receptor.
-
公开(公告)号:EP4395840A1
公开(公告)日:2024-07-10
申请号:EP22772889.6
申请日:2022-09-01
IPC分类号: A61K51/04 , A61K31/496 , C07B59/00 , C07D405/12 , C07D405/14 , C07D409/14 , G01N33/60 , A61P25/00 , A61K101/00 , A61K101/02
CPC分类号: A61K51/0459 , A61P25/00 , G01N33/60 , A61K31/496 , C07B59/002 , C07D405/14 , C07D409/14 , G01N2333/9220130101 , C07D405/12
-
公开(公告)号:EP4392028A1
公开(公告)日:2024-07-03
申请号:EP22862009.2
申请日:2022-08-23
发明人: COZZI, Nicholas , DALEY, Paul
IPC分类号: A61K31/137 , C07B59/00
CPC分类号: C07B59/002 , C07B2200/0520130101 , C07D317/58 , A61K45/06 , A61K31/36
-
-
公开(公告)号:EP4359389A1
公开(公告)日:2024-05-01
申请号:EP22743674.8
申请日:2022-06-21
发明人: GRAUPE, Michael , GUERRERO, Juan A. , HOLMBO, Stephen D. , JACOBSEN, Jesse M. , KOBAYASHI, Tetsuya , PATEL, Leena B. , WEAVER, Heath A. , XU, Jie , YEUNG, Suet C.
IPC分类号: C07D239/95 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D405/12 , C07D413/04 , C07D413/14 , C07D417/12 , C07D471/04 , C07D487/08 , C07B59/00 , A61P31/18 , A61P31/20 , A61P35/00 , A61P35/04 , A61K31/517
CPC分类号: A61P35/00 , A61P35/04 , A61P31/18 , A61P31/20 , C07D239/95 , C07D471/04 , C07D413/04 , C07D403/04 , C07D401/12 , C07D417/12 , C07D403/12 , C07D401/04 , C07D405/12 , C07D401/14 , C07D413/14 , C07D487/08 , C07B59/002
-
公开(公告)号:EP3411031A1
公开(公告)日:2018-12-12
申请号:EP17748198.3
申请日:2017-02-03
申请人: Cinrx Pharma, LLC
发明人: PEARCE, Catherine , ISAACSOHN, Jon , PATEL, Piyush
IPC分类号: A61K31/454 , A61P1/08 , C07D401/14
CPC分类号: C07D401/14 , A61K31/454 , C07B59/002 , C07B2200/05
摘要: Deuterated domperidone compositions, methods of synthesis, methods of use, and dosing formulations providing beneficial safety and other effects.
-
公开(公告)号:EP3389729A1
公开(公告)日:2018-10-24
申请号:EP16876527.9
申请日:2016-12-14
申请人: Medical Research Council , University of Delaware , The University of North Carolina at Chapel Hill
发明人: FOX, Joseph , LI, Zibo , LIU, Yu , TAYLOR, Michael Thompson , SVATUNEK, Dennis , ROHLFING, Katarina , WANG, Mengzhe , WU, Zhanhong , VANNAM, Raghu , WALLACE, Stephen , CHIN, Jason W.
IPC分类号: A61K51/04 , C07D257/08
CPC分类号: A61K51/082 , A61K51/088 , C07B59/001 , C07B59/002 , C07D225/02 , C07D257/02 , C07D311/44 , C07D313/18 , C07D403/12 , C07D405/12 , C07F7/0812
摘要: Conformationally strained irans-cycloalkenes and derivatives thereof suitable for radiolabeling in a subject in need thereof.
-
公开(公告)号:EP3387445A1
公开(公告)日:2018-10-17
申请号:EP16816622.1
申请日:2016-12-09
CPC分类号: C07B59/002 , C07B2200/05 , C07D403/12 , C12Q1/6872 , C40B40/04 , G01N33/58 , G01N33/6893 , G01N2458/15 , G01N2560/00
摘要: wherein X is a reporter moiety having an exact mass, L is a bond cleavable by collision in a mass spectrometer, M is a mass modifier, and Re is a) a reactive functionality for attaching the mass label to an analyte or b) the analyte, wherein each mass label in the set has an integer mass, wherein each mass label in the set has the same integer mass, and wherein the set comprises two or more subsets of mass labels, each subset comprising one, two or more mass labels, and wherein, when the subset comprises two or more mass labels, the exact mass of the reporter moiety X of each mass label in the subset is different from the exact mass of the reporter moiety X of the mass labels in the same subset and in all other subsets, and wherein each mass label is distinguishable by mass spectrometry.
-
公开(公告)号:EP3184526B1
公开(公告)日:2018-10-03
申请号:EP16197502.4
申请日:2006-12-12
发明人: RODGERS, James D. , SHEPARD, Stacey , MADUSKUIE, Thomas P. , WANG, Haisheng , FALAHATPISHEH, Nikoo , RAFALSKI, Maria , ARVANITIS, Argyrios G. , STORACE, Louis , JALLURI, Ravi Kumar , FRIDMAN, Jordan S. , VADDI, Krishna
IPC分类号: C07D471/04 , C07D487/04 , A61K31/395 , A61P17/00 , A61P35/00 , A61P37/00
CPC分类号: A61K31/519 , A61K9/0014 , A61K9/0053 , A61K9/20 , A61K31/573 , A61K45/06 , C07B59/002 , C07B2200/05 , C07D417/04 , C07D471/04 , C07D487/04
摘要: The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines (I) and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.
-
-
-
-
-
-
-
-
-